| scholarly article | Q13442814 |
| P50 | author | Yee-Shin Lin | Q117789619 |
| Trai-Ming Yeh | Q35703871 | ||
| Scott B Halstead | Q60059357 | ||
| Chiou-Feng Lin | Q91039135 | ||
| P2093 | author name string | Ching-Chuan Liu | |
| Jyh-Hsiung Huang | |||
| Huan-Yao Lei | |||
| Kao-Jean Huang | |||
| Lien-Cheng Chen | |||
| Thanh Hung Nguyen | |||
| Thi Que Huong Vu | |||
| Quang Ha Do | |||
| Bich Lien Le | |||
| Thi My Lam | |||
| Trong Lan Nguyen | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cytokine | Q212354 |
| Dengue virus | Q476209 | ||
| dengue hemorrhagic fever | Q18554268 | ||
| P304 | page(s) | 221-232 | |
| P577 | publication date | 2004-01-09 | |
| P1433 | published in | Journal of Infectious Diseases | Q4051141 |
| P1476 | title | Dengue hemorrhagic fever in infants: a study of clinical and cytokine profiles | |
| P478 | volume | 189 |
| Q35641137 | A Highly Sensitive Diagnostic System for Detecting Dengue Viruses Using the Interaction between a Sulfated Sugar Chain and a Virion |
| Q27490166 | A Prospective Nested Case-Control Study of Dengue in Infants: Rethinking and Refining the Antibody-Dependent Enhancement Dengue Hemorrhagic Fever Model |
| Q41929302 | A predictive score for hypotension in patients with confirmed dengue fever in Cayenne Hospital, French Guiana |
| Q40040951 | Alpha-mangostin inhibits both dengue virus production and cytokine/chemokine expression |
| Q43046621 | An IRF-3-, IRF-5-, and IRF-7-Independent Pathway of Dengue Viral Resistance Utilizes IRF-1 to Stimulate Type I and II Interferon Responses |
| Q27481478 | An Immunogenic and Protective Alphavirus Replicon Particle-Based Dengue Vaccine Overcomes Maternal Antibody Interference in Weanling Mice |
| Q34353489 | An emerging role for the anti-inflammatory cytokine interleukin-10 in dengue virus infection. |
| Q40429067 | An in vitro model for dengue virus infection that exhibits human monocyte infection, multiple cytokine production and dexamethasone immunomodulation |
| Q33844674 | An interferon-gamma-related cytokine storm in SARS patients |
| Q34550268 | Antibody-dependent enhancement infection facilitates dengue virus-regulated signaling of IL-10 production in monocytes. |
| Q36628520 | Antibody-dependent enhancement of dengue virus infection inhibits RLR-mediated Type-I IFN-independent signalling through upregulation of cellular autophagy |
| Q27321668 | Aspects of T Cell-Mediated Immunity Induced in Mice by a DNA Vaccine Based on the Dengue-NS1 Antigen after Challenge by the Intracerebral Route |
| Q36487320 | Association between magnitude of the virus-specific plasmablast response and disease severity in dengue patients |
| Q33785818 | Both viremia and cytokine levels associate with the lack of severe disease in secondary dengue 1 infection among adult Chinese patients |
| Q34074313 | Cardiac function in Vietnamese patients with different dengue severity grades |
| Q40341836 | Cell type specificity and host genetic polymorphisms influence antibody-dependent enhancement of dengue virus infection |
| Q36523226 | Characterization of a model of lethal dengue virus 2 infection in C57BL/6 mice deficient in the alpha/beta interferon receptor |
| Q27490805 | Clinical Findings and Pro-Inflammatory Cytokines in Dengue Patients in Western India: A Facility-Based Study |
| Q27491351 | Clinical and Virological Features of Dengue in Vietnamese Infants |
| Q39985526 | Clinical isolates of dengue virus with distinctive susceptibility to nitric oxide radical induce differential gene responses in THP-1 cells |
| Q90443656 | Clinical, Virological, and Cytokine Profiles of Children Infected with Dengue Virus during the Outbreak in Southern Vietnam in 2017 |
| Q40358285 | Coagulopathy parameters in patients with Crimean-Congo hemorrhagic fever and its relation with mortality |
| Q27485131 | Complement Protein C1q Inhibits Antibody-Dependent Enhancement of Flavivirus Infection in an IgG Subclass-Specific Manner |
| Q36895622 | Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells |
| Q38016235 | Controversies in dengue pathogenesis |
| Q35590817 | Correlation between serum levels of anti-endothelial cell autoantigen and anti-dengue virus nonstructural protein 1 antibodies in dengue patients |
| Q36447136 | Correlation of Clinicohaematological Parameters in Paediatric Dengue: A Retrospective Study |
| Q35071222 | Corticosteroids for dengue - why don't they work? |
| Q102372418 | Current Understanding of the Pathogenesis of Dengue Virus Infection |
| Q35830864 | Current advances in dengue diagnosis |
| Q36085940 | Cytokine Profile of Children Hospitalized with Virologically-Confirmed Dengue during Two Phase III Vaccine Efficacy Trials |
| Q61803857 | Cytokine Signature Associated with Disease Severity in Dengue |
| Q29619772 | Dengue |
| Q35641205 | Dengue Virus Infection with Highly Neutralizing Levels of Cross-Reactive Antibodies Causes Acute Lethal Small Intestinal Pathology without a High Level of Viremia in Mice. |
| Q35865823 | Dengue and soluble mediators of the innate immune system |
| Q40090825 | Dengue fever in infants: report of three cases |
| Q30245613 | Dengue fever virus in Pakistan: effects of seasonal pattern and temperature change on distribution of vector and virus |
| Q35739855 | Dengue hemorrhagic fever-associated immunomediators induced via maturation of dengue virus nonstructural 4B protein in monocytes modulate endothelial cell adhesion molecules and human microvascular endothelial cells permeability |
| Q27489388 | Dengue in Vietnamese Infants—Results of Infection‐Enhancement Assays Correlate with Age‐Related Disease Epidemiology, and Cellular Immune Responses Correlate with Disease Severity |
| Q33427326 | Dengue in children: a systematic review of clinical and laboratory factors associated with severity |
| Q40140011 | Dengue virus NS1 protein activates cells via Toll-like receptor 4 and disrupts endothelial cell monolayer integrity |
| Q28278881 | Dengue virus life cycle: viral and host factors modulating infectivity |
| Q24645380 | Dengue virus pathogenesis: an integrated view |
| Q27026302 | Dengue viruses - an overview |
| Q40313055 | Dengue-2 and yellow fever 17DD viruses infect human dendritic cells, resulting in an induction of activation markers, cytokines and chemokines and secretion of different TNF-α and IFN-α profiles |
| Q55109773 | Dengue-Virus-Infektionen |
| Q27477724 | Dengue-virus-infected dendritic cells trigger vascular leakage through metalloproteinase overproduction |
| Q40420543 | Differences in global gene expression in peripheral blood mononuclear cells indicate a significant role of the innate responses in progression of dengue fever but not dengue hemorrhagic fever |
| Q27485627 | Differential Gene Expression Changes in Children with Severe Dengue Virus Infections |
| Q40261835 | Environmental influences on antibody-enhanced dengue disease outcomes. |
| Q33428741 | Epidemiology of Dengue Among Children Aged < 18 Months-Puerto Rico, 1999-2011. |
| Q35866928 | Epidemiology of Infant Dengue Cases Illuminates Serotype-Specificity in the Interaction between Immunity and Disease, and Changes in Transmission Dynamics |
| Q33410676 | Factors associated with dengue shock syndrome: a systematic review and meta-analysis |
| Q27490377 | Gene Expression Profiling during Early Acute Febrile Stage of Dengue Infection Can Predict the Disease Outcome |
| Q36933241 | HLA-B∗44 Is Associated with Dengue Severity Caused by DENV-3 in a Brazilian Population |
| Q33419779 | High producing tumor necrosis factor alpha gene alleles in protection against severe manifestations of dengue |
| Q37793734 | How Innate Immune Mechanisms Contribute to Antibody-Enhanced Viral Infections |
| Q40341498 | Human antibodies against dengue enhance dengue viral infectivity without suppressing type I interferon secretion in primary human monocytes |
| Q40042448 | IL-10 and socs3 Are Predictive Biomarkers of Dengue Hemorrhagic Fever |
| Q40262679 | IL-17 level in patients with Dengue virus infection & its association with severity of illness |
| Q33430763 | Immune Response to Dengue Virus Infection in Pediatric Patients in New Delhi, India--Association of Viremia, Inflammatory Mediators and Monocytes with Disease Severity |
| Q33924674 | Immune correlates for dengue vaccine development |
| Q34770828 | Immune response during adverse events after 17D-derived yellow fever vaccination in Europe |
| Q34261827 | Immunodominance changes as a function of the infecting dengue virus serotype and primary versus secondary infection |
| Q92001054 | Immunodomination of Serotype-Specific CD4+ T-Cell Epitopes Contributed to the Biased Immune Responses Induced by a Tetravalent Measles-Vectored Dengue Vaccine |
| Q39333506 | Immunopathogenesis of dengue hemorrhagic fever: contribution to the study of human liver lesions |
| Q24815761 | Increased PAI-1 plasma levels and risk of death from dengue: no association with the 4G/5G promoter polymorphism |
| Q40380663 | Increment of interleukin 6, tumour necrosis factor alpha, nitric oxide, C-reactive protein and apoptosis in dengue |
| Q40307795 | Infection and activation of human peripheral blood monocytes by dengue viruses through the mechanism of antibody-dependent enhancement. |
| Q40480637 | Innate and adaptive cellular immunity in flavivirus-naïve human recipients of a live-attenuated dengue serotype 3 vaccine produced in Vero cells (VDV3). |
| Q36228889 | Innate immune responses to dengue virus |
| Q91962220 | Insight into the Tropism of Dengue Virus in Humans |
| Q33962671 | Interacting roles of immune mechanisms and viral load in the pathogenesis of crimean-congo hemorrhagic fever. |
| Q34671059 | Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes |
| Q35146621 | Lack of clinical manifestations in asymptomatic dengue infection is attributed to broad down-regulation and selective up-regulation of host defence response genes |
| Q36300302 | Lactate based optical screening of dengue virus infection in human sera using Raman spectroscopy |
| Q27315772 | Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification |
| Q33380611 | Liver injury caused by antibodies against dengue virus nonstructural protein 1 in a murine model |
| Q35095611 | Low adiposity during early infancy is associated with a low risk for developing dengue hemorrhagic fever: a preliminary model |
| Q35097469 | Maternal antibody and viral factors in the pathogenesis of dengue virus in infants |
| Q24570135 | Maturation of dengue virus nonstructural protein 4B in monocytes enhances production of dengue hemorrhagic fever-associated chemokines and cytokines |
| Q34746720 | Microbial translocation is associated with extensive immune activation in dengue virus infected patients with severe disease |
| Q38878831 | Modelling original antigenic sin in dengue viral infection |
| Q54217627 | Modulation of Dengue/Zika Virus Pathogenicity by Antibody-Dependent Enhancement and Strategies to Protect Against Enhancement in Zika Virus Infection. |
| Q34593960 | Molecular mimicry between dengue virus and coagulation factors induces antibodies to inhibit thrombin activity and enhance fibrinolysis |
| Q27487753 | Molecular profiling of T-helper immune genes during dengue virus infection |
| Q27486434 | Multiplex cytokine profile from dengue patients: MIP-1beta and IFN-gamma as predictive factors for severity |
| Q54319582 | Neurological Manifestations of Dengue Infection. |
| Q38646923 | New insights into the immunopathology and control of dengue virus infection |
| Q27486912 | Phenotyping of peripheral blood mononuclear cells during acute dengue illness demonstrates infection and increased activation of monocytes in severe cases compared to classic dengue fever |
| Q39682296 | Positive transcription elongation factor b (P-TEFb) contributes to dengue virus-stimulated induction of interleukin-8 (IL-8). |
| Q37007528 | Primary dengue haemorrhagic fever in patients from northeast of Brazil is associated with high levels of interferon-β during acute phase |
| Q36720238 | Primary dengue virus infections induce differential cytokine production in Mexican patients. |
| Q38919411 | Prospective birth cohort in a hyperendemic dengue area in Northeast Brazil: methods and preliminary results |
| Q29619608 | Prospects for a dengue virus vaccine |
| Q40405263 | Proteomic analysis of endothelial cell autoantigens recognized by anti-dengue virus nonstructural protein 1 antibodies |
| Q27477646 | Recent Advances in Deciphering Viral and Host Determinants of Dengue Virus Replication and Pathogenesis |
| Q33407555 | Review of Dengue hemorrhagic fever fatal cases seen among adults: a retrospective study |
| Q39591265 | Risk factors and clinical features associated with severe dengue infection in adults and children during the 2001 epidemic in Chonburi, Thailand |
| Q90403030 | Role of Interleukin-10 and Abdominopelvic Ultrasound as a Potential Predictor of Disease Severity in Dengue Hemorrhagic Fever |
| Q40275323 | Roles for endothelial cells in dengue virus infection |
| Q39302764 | Serological characterization of dengue virus infections observed among dengue hemorrhagic fever/dengue shock syndrome cases in upper Myanmar |
| Q40161217 | Serum levels of IL-8, IFNγ, IL-10, and TGF β and their gene expression levels in severe and non-severe cases of dengue virus infection |
| Q39393893 | Serum levels of interleukin-6, tumor necrosis factor-alpha and interferon-gamma in infants with and without dengue |
| Q36073685 | Serum levels of soluble vascular cell adhesion molecules may correlate with the severity of dengue virus-1 infection in adults |
| Q35753613 | Source and Purity of Dengue-Viral Preparations Impact Requirement for Enhancing Antibody to Induce Elevated IL-1β Secretion: A Primary Human Monocyte Model |
| Q26252507 | Specificity, cross-reactivity and function of antibodies elicited by Zika virus infection |
| Q33414009 | T-cell immunity to infection with dengue virus in humans |
| Q35402842 | Tetravalent recombinant dengue virus-like particles as potential vaccine candidates: immunological properties |
| Q27490855 | The Incidence, Characteristics, and Presentation of Dengue Virus Infections during Infancy |
| Q33817714 | The Role of Heterotypic DENV-specific CD8+T Lymphocytes in an Immunocompetent Mouse Model of Secondary Dengue Virus Infection |
| Q36531302 | The WHO dengue classification and case definitions: time for a reassessment |
| Q39210623 | The association of cytokines with severe dengue in children |
| Q36978907 | The cytokine response of U937-derived macrophages infected through antibody-dependent enhancement of dengue virus disrupts cell apical-junction complexes and increases vascular permeability |
| Q54408573 | The dengue virus envelope protein induced PAI-1 gene expression via MEK/ERK pathways. |
| Q37448171 | The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity |
| Q37135489 | The successful induction of T-cell and antibody responses by a recombinant measles virus-vectored tetravalent dengue vaccine provides partial protection against dengue-2 infection. |
| Q36342501 | The virus-immunity ecosystem |
| Q33389673 | Timing of CD8+ T cell responses in relation to commencement of capillary leakage in children with dengue |
| Q27480996 | Transcriptional Activation of Interferon-Stimulated Genes but Not of Cytokine Genes after Primary Infection of Rhesus Macaques with Dengue Virus Type 1 |
| Q39270949 | Transcriptional Profiling Confirms the Therapeutic Effects of Mast Cell Stabilization in a Dengue Disease Model |
| Q37181382 | Vascular endothelium: the battlefield of dengue viruses |
| Q92538927 | Wanted Dead or Alive: A Correlate of Protection Against Dengue Virus |
Search more.